Licha K, Olbrich C
Schering AG, Research Laboratories, Müllerstrasse 178, D-13342 Berlin, Germany.
Adv Drug Deliv Rev. 2005 Jun 15;57(8):1087-108. doi: 10.1016/j.addr.2005.01.021.
Optical imaging combines a variety of different diagnostic modalities which have shown great promise for biomedical imaging and as a tool in drug discovery. Several different principles to identify and characterize fundamental processes at the organ, tissue, cellular and molecular level have been exploited, supported by the design of novel imaging agents and biomolecular reporter systems. New optical imaging procedures will contribute considerably to the improvement of the knowledge of disease processes and the more efficient evaluation of drug effects in living laboratory animals. They may also find new diagnostic and therapeutic applications in human clinical practices. These techniques can be used in the field of molecular imaging to allow both visualization and quantification of molecular events associated with disease in a non-invasive and radiation-free manner using relatively simple equipment. The different aspects of imaging instrumentation and methods; the achievements in synthesis and evaluation of novel imaging agents and biochemical reporters; as well as the opportunities of optical imaging in drug delivery, drug discovery and imaging diagnostics will be discussed in this review article.
光学成像结合了多种不同的诊断方式,这些方式在生物医学成像以及作为药物研发工具方面已展现出巨大潜力。借助新型成像剂和生物分子报告系统的设计,人们利用了几种不同原理来识别和表征器官、组织、细胞及分子水平的基本过程。新的光学成像程序将极大地有助于增进对疾病过程的了解,并更有效地评估活体实验动物中的药物效果。它们还可能在人类临床实践中找到新的诊断和治疗应用。这些技术可用于分子成像领域,以相对简单的设备,通过非侵入性且无辐射的方式实现与疾病相关分子事件的可视化和定量分析。本文将讨论成像仪器和方法的不同方面、新型成像剂和生化报告物的合成与评估成果,以及光学成像在药物递送、药物研发和成像诊断中的机遇。